Serina Therapeutics, Inc.SERNYSE
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+97.4%
5Y CAGR+27.6%
Year-over-Year Change
Research and development spending
3Y CAGR
+97.4%/yr
vs -26.4%/yr prior
5Y CAGR
+27.6%/yr
Recent acceleration
Acceleration
+123.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.4x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $12.10M | +61.8% |
| 2024 | $7.48M | +213.2% |
| 2023 | $2.39M | +51.8% |
| 2022 | $1.57M | -58.6% |
| 2021 | $3.80M | +6.0% |
| 2020 | $3.58M | -33.0% |
| 2019 | $5.35M | -0.1% |
| 2018 | $5.35M | +1.6% |
| 2017 | $5.27M | -33.1% |
| 2016 | $7.87M | - |